PAR paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-37

  1. 2,019 Posts.
    lightbulb Created with Sketch. 2397
    Hi Zenox, noting your scepticism about whether these results imply impact on fibrosis, do you happen to know what the standard treatment is for acute inflammatory response - and how iPPS compares? I suppose what i'm ultimately trying to divine is whether this would be material on it's own and could displace current treatments?


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.5¢
Change
-0.015(3.49%)
Mkt cap ! $164.9M
Open High Low Value Volume
43.5¢ 44.0¢ 41.5¢ $216.2K 510.9K

Buyers (Bids)

No. Vol. Price($)
1 12344 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 2286 1
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.